Sweet's syndrome associated with upper respiratory tract streptococcal infection: "wait-and-see" strategy or anecdotal use of corticosteroids?

Hippokratia

Volumn 15, Issue 3, 2011, Pages 283-

  Lallas, A ^a   Tzellos, T G ^a   Papageorgiou, M ^a   Mandekou Lefaki, I ^a  

^a State Hospital for Skin and Venereal Diseases   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTISTREPTOLYSIN; C REACTIVE PROTEIN; CORTICOSTEROID;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; CASE REPORT; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LETTER; LEUKOCYTOSIS; MALE; PHYSICAL EXAMINATION; STREPTOCOCCUS INFECTION; UPPER RESPIRATORY TRACT INFECTION;

EID: 79959845310     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol. 2003; 42: 761-778.
2. Noursadeghi M, Bickerstaff MC, Herbert J, Moyes D, Cohen J, Pepys MB. Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. J Immunol. 2002; 169: 913-919.
3. Newton R, King EM, Gong W, Rider CF, Staples KJ, Holden NS, et al. Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Biochem J. 2010; 427: 113-124.